Alejandro Almodóvar

Tomàs Garriga, Alejandro Almodóvar, Axel Brando et al.

Individualized treatment selection with continuous actions requires accurate causal response estimation in decision-relevant regions, rather than uniformly over the entire action space. Estimating a global causal response surface and then choosing the treatment that maximizes it can therefore be suboptimal, since standard estimation objectives allocate modeling effort according to the observed treatment distribution rather than the regions that determine the optimal decision. While decision-aware approaches have been studied in unconfounded settings, this problem remains underexplored in proximal causal inference, where proxy variables and bridge functions enable identification under suitable assumptions even in the presence of hidden confounding. Despite recent progress, proximal methods have primarily focused on treatment-effect and potential-outcome estimation rather than treatment selection and optimal decision-making. To bridge this gap, we introduce a policy-targeted weighted bridge loss that emphasizes decision-relevant treatment regions while retaining global stabilization. We prove a regret bound showing that the proposed weighted bridge loss controls treatment-selection regret through a weighted ill-posedness constant. We instantiate the framework in decision-aware variants of several proximal bridge solvers, yielding practical algorithms that alternate between weighted bridge estimation, response-surface projection, policy update, and weight refinement. Empirically, we find that decision-aware weighting reduces regret across several bridge solvers, suggesting improved treatment selection in proximal settings.

Alejandro Almodóvar, Patricia A. Apellániz, Santiago Zazo et al.

Deep neural networks achieve state-of-the-art performance in estimating heterogeneous treatment effects, but their opacity limits trust and adoption in sensitive domains such as medicine, economics, and public policy. Building on well-established and high-performing causal neural architectures, we propose causalKANs, a framework that transforms neural estimators of conditional average treatment effects (CATEs) into Kolmogorov--Arnold Networks (KANs). By incorporating pruning and symbolic simplification, causalKANs yields interpretable closed-form formulas while preserving predictive accuracy. Experiments on benchmark datasets demonstrate that causalKANs perform on par with neural baselines in CATE error metrics, and that even simple KAN variants achieve competitive performance, offering a favorable accuracy--interpretability trade-off. By combining reliability with analytic accessibility, causalKANs provide auditable estimators supported by closed-form expressions and interpretable plots, enabling trustworthy individualized decision-making in high-stakes settings. We release the code for reproducibility at https://github.com/aalmodovares/causalkans .

Alejandro Almodóvar, Adrián Javaloy, Juan Parras et al.

We introduce DeCaFlow, a deconfounding causal generative model. Training once per dataset using just observational data and the underlying causal graph, DeCaFlow enables accurate causal inference on continuous variables under the presence of hidden confounders. Specifically, we extend previous results on causal estimation under hidden confounding to show that a single instance of DeCaFlow provides correct estimates for all causal queries identifiable with do-calculus, leveraging proxy variables to adjust for the causal effects when do-calculus alone is insufficient. Moreover, we show that counterfactual queries are identifiable as long as their interventional counterparts are identifiable, and thus are also correctly estimated by DeCaFlow. Our empirical results on diverse settings (including the Ecoli70 dataset, with 3 independent hidden confounders, tens of observed variables and hundreds of causal queries) show that DeCaFlow outperforms existing approaches, while demonstrating its out-of-the-box applicability to any given causal graph. An implementation can be found in https://github.com/aalmodovares/DeCaFlow

Alejandro Almodóvar, Patricia A. Apellániz, Alba Garrido et al.

Why should a clinician trust an Artificial Intelligence (AI) prediction? Despite the increasing accuracy of machine learning methods in medicine, the lack of transparency continues to hinder their adoption in clinical practice. In this work, we explore Kolmogorov-Arnold Networks (KANs) for clinical classification tasks on tabular data. In contrast to traditional neural networks, KANs are function-based architectures that offer intrinsic interpretability through transparent, symbolic representations. We introduce \emph{Logistic-KAN}, a flexible generalization of logistic regression, and \emph{Kolmogorov-Arnold Additive Model (KAAM)}, a simplified additive variant that delivers transparent, symbolic formulas. Unlike ``black-box'' models that require post-hoc explainability tools, our models support built-in patient-level insights, intuitive visualizations, and nearest-patient retrieval. Across multiple health datasets, our models match or outperform standard baselines, while remaining fully interpretable. These results position KANs as a promising step toward trustworthy AI that clinicians can understand, audit, and act upon. We release the code for reproducibility in \codeurl.

Alba Garrido, Alejandro Almodóvar, Patricia A. Apellániz et al.

Accurate survival prediction is critical in oncology for prognosis and treatment planning. Traditional approaches often rely on a single data modality, limiting their ability to capture the complexity of tumor biology. To address this challenge, we introduce a multimodal deep learning framework for survival analysis capable of modeling both single and competing risks scenarios, evaluating the impact of integrating multiple medical data sources on survival predictions. We propose SAMVAE (Survival Analysis Multimodal Variational Autoencoder), a novel deep learning architecture designed for survival prediction that integrates six data modalities: clinical variables, four molecular profiles, and histopathological images. SAMVAE leverages modality specific encoders to project inputs into a shared latent space, enabling robust survival prediction while preserving modality specific information. Its parametric formulation enables the derivation of clinically meaningful statistics from the output distributions, providing patient-specific insights through interactive multimedia that contribute to more informed clinical decision-making and establish a foundation for interpretable, data-driven survival analysis in oncology. We evaluate SAMVAE on two cancer cohorts breast cancer and lower grade glioma applying tailored preprocessing, dimensionality reduction, and hyperparameter optimization. The results demonstrate the successful integration of multimodal data for both standard survival analysis and competing risks scenarios across different datasets. Our model achieves competitive performance compared to state-of-the-art multimodal survival models. Notably, this is the first parametric multimodal deep learning architecture to incorporate competing risks while modeling continuous time to a specific event, using both tabular and image data.